# JULUCA
> **NDA210192** · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2017-11-21
## Drug
- **FDA Application Number:** NDA210192
- **Application type:** New Drug Application
- **Brand name:** JULUCA
- **Generic name:** DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE
- **Active ingredients:** DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VIIV HLTHCARE
- **Manufacturer:** ViiV Healthcare Company
- **First approval:** 2017-11-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210192)
---
*MORVS · CC0 1.0*